Purchasing Tips: How to Verify Glucagon CAMP Product Qualification
Published: July 15, 2026 17:13
Author: Jean Edwards
Abstract: Verifying Glucagon CAMP product qualification requires rigorous assessment of peptide composition, purity (>98% by HPLC), and bioactivity via cAMP ELISA assays. Market trends show a 12.3% CAGR in therapeutic peptides, with Novo Nordisk and Eli Lilly dominating glucagon analogs. Key differentiators include lyophilization stability (vs. liquid formulations) and cold-chain logistics (-20°C compliance). Certifications (GMP, ISO 9001) and batch-specific COAs are critical. Selection prioritizes impurity profiles (<0.5% endotoxins) and receptor-binding specificity. Industry shifts toward dual-agonist peptides demand updated qualification protocols.